HHS OKs FDA’s Supersized Office of Generic Drugs

Washington Drug Letter
A A
HHS has approved the overhaul of the FDA’s Office of Generic Drugs (OGD), allowing the agency to move most of its functions relating to generic drugs under one roof.

To View This Article:

Login

Buy This Article Now

Add this article to your cart for $25.00